Compounds > camptothecin
Page last updated: 2024-08-22

camptothecin and thyroxine

camptothecin has been researched along with thyroxine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Innocenti, F; Ramírez, J; Ratain, MJ; Yoder Graber, AL1
Abnous, K; Alibolandi, M; Farzad, SA; Ramezani, M; Rezvani, R; Taghdisi, SM1
Abnous, K; Alibolandi, M; Amel Farzad, S; Kalalinia, F; Mohammadi, M; Ramezani, M; Taghdisi, SM1

Other Studies

4 other study(ies) available for camptothecin and thyroxine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers.
    Pharmacogenetics and genomics, 2007, Volume: 17, Issue:8

    Topics: Camptothecin; DNA, Complementary; Flavonoids; Genotype; Glucuronates; Glucuronides; Glucuronosyltransferase; Humans; Kinetics; Liver; Microsomes, Liver; Phenotype; Piperidines; Polymorphism, Genetic; Thyroxine

2007
Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    International journal of pharmaceutics, 2017, Oct-30, Volume: 532, Issue:1

    Topics: Adenocarcinoma; Animals; Camptothecin; Cell Line, Tumor; Colonic Neoplasms; Drug Delivery Systems; Female; HT29 Cells; Humans; Integrin alphaVbeta3; Mice; Mice, Inbred BALB C; Thyroxine

2017
Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38.
    Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup2

    Topics: Animals; Antineoplastic Agents; Biological Transport; Camptothecin; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Liberation; Female; Humans; Integrin alphaVbeta3; Mice; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine; Xenograft Model Antitumor Assays

2018